- Home
- ROIV vs TSCO Comparison
ROIV vs TSCO Comparison
Compare ROIV & TSCO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | ROIV | TSCO |
|---|---|---|
| Founded | 2014 | 1938 |
| Country | United Kingdom | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | RETAIL: Building Materials |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 21.0B | 19.3B |
| IPO Year | 2021 | 1996 |
Fundamental Metrics
Financial Performance| Metric | ROIV | TSCO |
|---|---|---|
| Price | $28.21 | $30.30 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 9 | 22 |
| Target Price | $28.94 | ★ $53.05 |
| AVG Volume (30 Days) | 5.8M | ★ 12.8M |
| Earning Date | 05-28-2026 | 04-21-2026 |
| Dividend Yield | N/A | ★ 2.76% |
| EPS Growth | N/A | ★ 0.98 |
| EPS | N/A | ★ 0.31 |
| Revenue | $8,260,000.00 | ★ $15,524,046,000.00 |
| Revenue This Year | N/A | $7.32 |
| Revenue Next Year | $744.61 | $6.01 |
| P/E Ratio | ★ N/A | $102.52 |
| Revenue Growth | N/A | ★ 4.31 |
| 52 Week Low | $10.71 | $29.42 |
| 52 Week High | $32.79 | $63.99 |
Technical Indicators
Market Signals| Indicator | ROIV | TSCO |
|---|---|---|
| Relative Strength Index (RSI) | 44.33 | 34.48 |
| Support Level | $26.95 | $29.54 |
| Resistance Level | $30.10 | $31.96 |
| Average True Range (ATR) | 1.10 | 1.08 |
| MACD | -0.15 | 0.50 |
| Stochastic Oscillator | 7.69 | 34.32 |
Price Performance
Historical ComparisonAbout ROIV Roivant Sciences Ltd.
Roivant Sciences Ltd is a commercial-stage biopharmaceutical company dedicated to improving the delivery of healthcare to patients. It also incubates discovery-stage companies and health technology startups complementary to its biopharmaceutical business. Its drug candidate VTAMA (tapinarof) is a treatment of plaque psoriasis in adult patients and is in its commercial stage. The other drug candidates in their different stages of development are; Batoclimab, IMVT-1402, Brepocitinib, Namilumab, and others.
About TSCO Tractor Supply Company
Tractor Supply is the largest operator of retail farm and ranch stores in the United States. The company targets recreational farmers and ranchers and has little exposure to commercial and industrial farm operations. Currently, the company operates 2,395 of its namesake banners in 49 states, along with 207 Petsense by Tractor Supply stores. Stores are generally concentrated in rural communities rather than urban and suburban areas. In fiscal 2025, revenue consisted primarily of livestock, equine & agriculture (around 30%), companion animal (25%), and seasonal & recreation (around 25%).